Clinical concerns with premenstrual syndrome.
O'Brien
P M
PM
Department of Obstetrics and Gynaecology, School of Postgraduate Medicine, Keele University, Hartshill, Stoke-on-Trent, UK.
D003131:Combined Modality Therapy; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D001523:Mental Disorders / Q000150:complications*; D011293:Premenstrual Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000523:psychology / Q000628:therapy; D011374:Progesterone / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D003277:Contraceptives, Oral, Combined; D004967:Estrogens; D011374:Progesterone; D011372:Progestins; D017367:Selective Serotonin Reuptake Inhibitors